SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

Share Price is delayed by 15 minutes
Get Live Data
0.944    0.00 (0.00%)
Bid:
0.944
Ask:
0.946
Spread: 0.002 (0.212%)
Market Cap: $1.06b
BPCR Live PriceLast checked at - London Stock Exchange

Intraday Biopharma Cred. Share Chart

Director/PDMR Shareholding

19 Aug 2021 17:30

RNS Number : 2328J
BioPharma Credit PLC
19 August 2021
 

BIOPHARMA CREDIT PLC

 

Notification of Transactions by

Persons Discharging Managerial Responsibilities and

Persons Closely Associated with them

 

1.

Details of person discharging managerial responsibilities/person closely associated with them

a)

Name

Anita Hyman

2.

Reason for the notification

a)

Position / status

Person Closely Associated with Harry Hyman (Director of BioPharma Credit PLC)

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

BioPharma Credit PLC

b)

LEI

213800AV55PYXAS7SY24

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares of $0.01 each

 

 

GB00BDGKMY29

b)

Nature of the transaction

Purchase of Shares (acquired as part of dividend reinvestment)

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.7135

42

 

d)

Aggregated information

- Aggregated volume

 

- Price

N/A

 

 

e)

Date of the transaction

18.08.21

f)

Place of the transaction

London Stock Exchange (XLON)

    

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBLGDIUBBDGBC
Date   Source Headline
1st Sep 20252:26 pmRNSTotal Voting Rights
26th Aug 20257:00 amRNSNotice of Half Year Results
22nd Aug 20254:00 pmRNSNet Asset Value(s) and Monthly Factsheet
21st Aug 202512:07 pmRNSTransaction in Own Shares - Correction
20th Aug 20256:16 pmRNSTransaction in Own Shares
12th Aug 20255:39 pmRNSDirector/PDMR Shareholding
31st Jul 20257:00 amRNSAppointment of New Director
21st Jul 20254:00 pmRNSNet Asset Value(s) and Monthly Factsheet
18th Jul 20254:23 pmRNSHolding(s) in Company
1st Jul 202512:02 pmRNSSTATEMENT RE BIOCRYST
24th Jun 20253:39 pmRNSHolding(s) in Company
20th Jun 20254:00 pmRNSNet Asset Value(s) and Monthly Factsheet
18th Jun 20257:00 amRNSDividend Declaration
10th Jun 202510:56 amRNSDirector Declaration
9th Jun 20254:37 pmRNSResult of AGM
22nd May 20254:00 pmRNSNet Asset Value(s) and Monthly Factsheet
22nd May 20257:00 amRNSUPDATE ON INVESTMENT PORTFOLIO
12th May 20253:36 pmRNSDirector/PDMR Shareholding
9th May 20254:34 pmRNSNotice of Annual General Meeting
6th May 20257:00 amRNSUPDATE ON INVESTMENTS
1st May 202512:36 pmRNSTotal Voting Rights
28th Apr 20254:00 pmRNSNet Asset Value(s) and Monthly Factsheet
11th Apr 20256:15 pmRNSTransaction in Own Shares
8th Apr 20256:15 pmRNSTransaction in Own Shares
7th Apr 20256:15 pmRNSTransaction in Own Shares
4th Apr 20256:15 pmRNSTransaction in Own Shares
3rd Apr 20256:15 pmRNSTransaction in Own Shares
2nd Apr 20256:15 pmRNSTransaction in Own Shares
2nd Apr 20255:21 pmRNSHolding(s) in Company
2nd Apr 20252:35 pmRNSBIOGEN SETTLEMENT
1st Apr 20256:15 pmRNSTransaction in Own Shares
1st Apr 202511:56 amRNSTotal Voting Rights
31st Mar 20256:15 pmRNSTransaction in Own Shares
27th Mar 20256:15 pmRNSTransaction in Own Shares
26th Mar 20256:15 pmRNSTransaction in Own Shares
25th Mar 20256:15 pmRNSTransaction in Own Shares
25th Mar 20257:01 amRNSDividend Declaration
25th Mar 20257:00 amRNSAnnual Financial Report
24th Mar 20256:15 pmRNSTransaction in Own Shares
21st Mar 20256:15 pmRNSTransaction in Own Shares
21st Mar 20255:19 pmRNSHolding(s) in Company
21st Mar 20254:00 pmRNSNet Asset Value(s) and Monthly Factsheet
21st Mar 20257:00 amRNSSTATEMENT RE OPTINOSE, INC.
20th Mar 20256:15 pmRNSTransaction in Own Shares
20th Mar 20257:00 amRNSAppointment of Joint Corporate Broker
19th Mar 20256:15 pmRNSTransaction in Own Shares
18th Mar 20256:15 pmRNSTransaction in Own Shares
18th Mar 202512:26 pmRNSHolding(s) in Company
17th Mar 20256:15 pmRNSTransaction in Own Shares
14th Mar 20256:15 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.